Challenges for pet owners with canine lymphoma treatments
In an interview with dvm360®, Sue Ettinger, DVM, DACVIM (Oncology)—known as Dr Sue Cancer Vet—discusses reasons why some pet owners decline to have their dogs provided with treatment for lymphoma and how veterinarians can help clients address these challenges.
In an interview with dvm360®, Sue Ettinger, DVM, DACVIM (Oncology)—known as Dr Sue Cancer Vet—discusses multiple reasons why some pet owners decline to have their dogs provided with treatment for lymphoma and how veterinarians can help clients address these challenges.
View the video for the entire discussion. The following is a partial transcript:
Sue Ettinger, DVM, DACVIM (Oncology): The No. 1 reason ends up being cost, especially if they don’t have pet insurance. [Additionally, there is] the fear of chemotherapy side effects, even though, as we’ll go through with the owner, that chemotherapy is very well tolerated, a lot of people have preconceived notions that their pet isn’t going to tolerate it.
Newsletter
From exam room tips to practice management insights, get trusted veterinary news delivered straight to your inbox—subscribe to dvm360.
Torsemide for canine CHF: Emerging evidence and clinical benefits
June 5th 2025William Rausch, DVM, DACVIM (Cardiology), explains that torsemide offers at least equivalent efficacy to furosemide in canine CHF while significantly reducing short-term mortality/worsening events by approximately 50%.
Read More
